Studying hearing and balance damage from cisplatin in head and neck cancer
Part of Brain & nervous system, Cancer, Ear, nose & throat, Injuries & trauma clinical trials.
This study looks at how cisplatin chemotherapy affects hearing and balance in people with head and neck cancer. It compares those getting cisplatin-based treatment to those getting only radiation. The goal is to better understand and potentially reduce these side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with head and neck squamous cell carcinoma (a common type of head and neck cancer)
- You are between 18 and 85 years old
- You are scheduled to receive or have received cisplatin chemotherapy with radiation, or you are getting radiation alone (the control group)
- You do not have severe hearing loss (worse than a certain threshold on a hearing test)
- You have not used certain medications that can damage hearing (like furosemide or aminoglycoside antibiotics) in the last 3 months
- You are willing to sign a consent form and follow the study plan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called ACOU085 to prevent hearing loss in men with testicular cancer who are receiving cisplatin chemotherapy. If you meet the hearing and health criteria, you may be able to join and help see if this drug can protect your hearing.
This study looks at how radiotherapy, and possibly cisplatin chemotherapy, affect hearing in people treated for head and neck cancer. It may help doctors better predict hearing side effects and plan hearing monitoring or prevention.
This Phase 2 trial tests whether sodium thiosulfate and mannitol can reduce hearing damage (ototoxicity) in adults receiving cisplatin chemotherapy. It may help protect hearing while you get cancer treatment.
This Phase 2 trial tests whether a cholesterol medicine called atorvastatin can protect hearing in people with head and neck cancer receiving cisplatin plus radiation. If it works, it may reduce the chance or severity of treatment-related hearing damage.
This study looks at hearing problems caused by cancer treatments that can damage the ears or nervous system. It aims to better understand and diagnose these side effects to help patients.
This trial tests if taking N-acetylcysteine (NAC) can help prevent hearing loss caused by high-dose cisplatin chemotherapy. If you're getting cisplatin and are between 18 and 70, you may be able to join.
Hear when a new Ototoxic Hearing Loss trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.